Submissions from 2024
Applications of nitric oxide-releasing nanomaterials in dermatology: Skin infections and wound healing, Sara Abdel Azim, Cleo Whiting, and Adam J. Friedman
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial, Andrew Blauvelt, Zoe D. Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Janet DuBois, Seth B. Forman, Melinda Gooderham, Lawrence Green, Scott T. Guenthner, Adelaide A. Hebert, Edward Lain, Angela Y. Moore, Kim A. Papp, Matthew Zirwas, Saori Kato, Scott Snyder, David Krupa, Patrick Burnett, David R. Berk, and David H. Chu
Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients, Heather A. Brandling-Bennett, Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo-Soccio, Dominic O. Co, Kelly M. Cordoro, Megan L. Curran, Austin M. Dalrymple, Carsten Flohr, Ken B. Gordon, Diane Hanna, Alan D. Irvine, Susan Kim, A Yasmine Kirkorian, Irene Lara-Corrales, Jill Lindstrom, Amy S. Paller, Melissa Reyes, Wendy Smith Begolka, Wynnis L. Tom, Abby S. Van Voorhees, Ruth Ann Vleugels, Lara Wine Lee, Olivia Davies, and Elaine C. Siegfried
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations, Derek K. Chu, Lynda Schneider, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Stephen A. Martin, Monica O'Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Kathryn E. Wheeler, and Gordon H. Guyatt
Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis, Lawrence F. Eichenfield, Jonathan I. Silverberg, Adelaide A. Hebert, and Mark Boguniewicz
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor), Melinda Gooderham, Ronald Vender, Jeffrey Crowley, H Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, and Lawrence Green
Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis, Stella P. Hartono, Sheena Chatrath, Ozge N. Aktas, Stephanie A. Kubala, Korey Capozza, Ian A. Myles, Jonathan I. Silverberg, and Alan Schwartz
Insights from a joint pediatric dermatology-gynecology vulvar clinic: A retrospective study, Nikita Menta, Dillon Nussbaum, Aneka Khilnani, Tazim Dowlut-McElroy, and Kaiane A. Habeshian
Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis, Amy S. Paller, Lawrence J. Green, Nanette Silverberg, Stephen Stripling, Martina Cartwright, Carolyn Enloe, Nick Wells, Elaine Kearney Kowalewski, and Tomoko Maeda-Chubachi
Evaluating the Content and Quality of the Top 50 #Cosmeticdermatology Instagram Posts, Vincent A. Pecora, Erika T. McCormick, Alexis E. Carrington, and Pooja Sodha
Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019-2020, Margo J. Reeder, Aman Nihal, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Marie-Claude Houle, Brandon L. Adler, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Donald V. Belsito, Jiade Yu, Nina B. Botto, Chris M. Mowad, Cory A. Dunnick, and Vincent A. DeLeo
Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019-2020, Margo J. Reeder, Aman Nihal, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Marie-Claude Houle, Brandon L. Adler, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Donald V. Belsito, Jiade Yu, Nina B. Botto, Chris M. Mowad, Cory A. Dunnick, and Vincent A. DeLeo
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients, Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, David Rosmarin, Lawrence F. Eichenfield, Leslie Castelo-Soccio, Victor Huang, Seemal R. Desai, Samantha Walsh, Jonathan I. Silverberg, Amy S. Paller, Michele Rodrigues, Mark Weingarten, Shanthi Narla, Jackie Gardner, Michael Siegel, Sidra Ibad, and Nanette B. Silverberg
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients, Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, David Rosmarin, Lawrence F. Eichenfield, Leslie Castelo-Soccio, Victor Huang, Seemal R. Desai, Samantha Walsh, Jonathan I. Silverberg, Amy S. Paller, Michele Rodrigues, Mark Weingarten, Shanthi Narla, Jackie Gardner, Michael Siegel, Sidra Ibad, and Nanette B. Silverberg
Navigating the atopic dermatitis toolbox: Challenging scenarios and shared decision-making, Archana Samynathan and Jonathan I. Silverberg
A review of hair removal modalities in pediatric patients: Ethical and clinical considerations, Eric Sanfilippo, Leslie Castelo-Soccio, and Anna Yasmine Kirkorian
Validation of the Investigator Global Assessment of Chronic Hand Eczema (IGA-CHE): a new clinician reported outcome measure of CHE severity, Jonathan I. Silverberg, Tove Agner, Keith Baranowski, Ursula Plohberger, Henrik Thoning, Rob Arbuckle, Laura Grant, George Skingley, and Robert Bissonnette
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2), Jonathan I. Silverberg, Melinda J. Gooderham, Amy S. Paller, Mette Deleuran, Christopher G. Bunick, Linda F. Gold, DirkJan Hijnen, Brian M. Calimlim, Wan-Ju Lee, Henrique D. Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M. Platt, and Diamant Thaçi
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study, Jonathan I. Silverberg, Robert S. Kirsner, David J. Margolis, Michael Tharp, Daniela E. Myers, Karen Annis, Daniela Graham, Chuanbo Zang, Bonnie L. Vlahos, and Paul Sanders
Patch Testing With Nickel, Cobalt, and Chromium in Patients With Suspected Allergic Contact Dermatitis, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Joel G. DeKoven, Donald V. Belsito, Amber R. Atwater, James S. Taylor, Denis Sasseville, Margo J. Reeder, Marie-Claude Houle, Vincent A. DeLeo, Howard I. Maibach, Joseph F. Fowler, Kathryn A. Zug, Melanie D. Pratt, JiaDe Yu, Christen M. Mowad, Nina C. Botto, and Brandon L. Adler
Phosphorylated p38 MAP kinase expression by leucocytes is increased in allergic humans and associated with IgE responses, Jonathan I. Silverberg, Tamar A. Smith-Norowitz, Stephan Kohlhoff, and Rauno Joks
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001), Jonathan I. Silverberg, Bruce Strober, Brian Feinstein, Jinhua Xu, Emma Guttman-Yassky, Eric L. Simpson, Pauline Li, Malinda Longphre, Jing Song, Jiawang Guo, Jang Yun, Belinda Williams, Wubin Pan, Selwyn Ho, Raúl Collazo, and Zheng Wei
Dupilumab treatment improves signs, symptoms, quality of life and work productivity in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial, Eric L. Simpson, Jonathan I. Silverberg, Margitta Worm, Golara Honari, Koji Masuda, Ewa Sygula, Marie L. Schuttelaar, Eric Mortensen, Elizabeth Laws, Bolanle Akinlade, Naimish Patel, Jennifer Maloney, Heather Paleczny, Dimittri Delevry, Jing Xiao, Ariane Dubost-Brama, and Ashish Bansal
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial, Eric L. Simpson, Jonathan I. Silverberg, Margitta Worm, Golara Honari, Koji Masuda, Ewa Syguła, Marie L. Schuttelaar, Eric Mortensen, Elizabeth Laws, Bolanle Akinlade, Naimish Patel, Jennifer Maloney, Heather Paleczny, Dimittri Delevry, Jing Xiao, Ariane Dubost-Brama, and Ashish Bansal
The big picture: Terminology in laser medicine, Pooja Sodha, Jordan V. Wang, Roy G. Geronemus, and Paul M. Friedman
The big picture: Terminology in laser medicine, Pooja Sodha, Jordan V. Wang, Roy G. Geronemus, and Paul M. Friedman
The Skin Microbiome and its Significance for Dermatologists, Cleo Whiting, Sara Abdel Azim, and Adam Friedman
The Skin Microbiome and its Significance for Dermatologists, Cleo Whiting, Sara Abdel Azim, and Adam Friedman
Submissions from 2023
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity, Gabriela C. Baiocchi, Aristo Vojdani, Avi Z. Rosenberg, Elroy Vojdani, Gilad Halpert, Yuri Ostrinski, Israel Zyskind, Igor S. Filgueiras, Lena F. Schimke, Alexandre H. Marques, Lasse M. Giil, Yael B. Lavi, Jonathan I. Silverberg, Jason Zimmerman, Dana A. Hill, Amanda Thornton, Myungjin Kim, Roberta De Vito, Dennyson L. Fonseca, Desireé R. Plaça, Paula P. Freire, Niels O. Camara, Vera L. Calich, Carmen Scheibenbogen, Harald Heidecke, Miriam T. Lattin, Hans D. Ochs, Gabriela Riemekasten, Howard Amital, Yehuda Shoenfeld, and Otavio Cabral-Marques
Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Rosacea: Results From Two Phase III, Randomized, Vehicle-Controlled Trials, Neal D. Bhatia, Wm Philip Werschler, Hilary Baldwin, Jeffrey Sugarman, Lawrence J. Green, Ofra Levy-Hacham, Ori Nov, Vered Ram, and Linda Stein Gold
Estimands for atopic dermatitis clinical trials: expert opinion on the importance of intercurrent events, R Bissonnette, L F. Eichenfield, E Simpson, D Thaçi, K Kabashima, J P. Thyssen, E Guttman-Yassky, F P. Nunes, M Gamalo, F Ahmad, M Kuligowski, K Sun, C Pipper, A W. Christensen, P D'Angelo, M Milutinovic, A Guettner, and J I. Silverberg
The vIGA-AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council, Robert Bissonnette, Eric Simpson, Lawrence F. Eichenfield, Emma Guttman-Yassky, Jonathan I. Silverberg, Lisa A. Beck, Lorena Mija, Jacob P. Thyssen, Thomas Bieber, Kenji Kabashima, Elaine Siegfried, Georg Stingl, Peter van de Kerkhof, Gil Yosipovitch, Carle Paul, and Amy S. Paller
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review, Andrew Blauvelt, Richard G. Langley, Kenneth B. Gordon, Jonathan I. Silverberg, Kilian Eyerich, Morten O. Sommer, Jakob Felding, and Richard B. Warren
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review, Andrew Blauvelt, Richard G. Langley, Kenneth B. Gordon, Jonathan I. Silverberg, Kilian Eyerich, Morten O. Sommer, Jakob Felding, and Richard B. Warren
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials, Andrew Blauvelt, Jacob P. Thyssen, Emma Guttman-Yassky, Thomas Bieber, Esther Serra-Baldrich, Eric Simpson, David Rosmarin, Hany Elmaraghy, Eric Meskimen, Chitra R. Natalie, Zhuqing Liu, Chenjia Xu, Evangeline Pierce, MaryAnn Morgan-Cox, Esther Garcia Gil, and Jonathan I. Silverberg
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials, Andrew Blauvelt, Jacob P. Thyssen, Emma Guttman-Yassky, Thomas Bieber, Esther Serra-Baldrich, Eric Simpson, David Rosmarin, Hany Elmaraghy, Eric Meskimen, Chitra R. Natalie, Zhuqing Liu, Chenjia Xu, Evangeline Pierce, MaryAnn Morgan-Cox, Esther Garcia Gil, and Jonathan I. Silverberg
Atopic dermatitis yardstick update, Mark Boguniewicz, Luz Fonacier, Emma Guttman-Yassky, Peck Y. Ong, and Jonathan I. Silverberg
Ulcerated diaper dermatitis: Child abuse mimicker, Stella A. Caldas, Emily Murphy, Kaiane Habeshian, Anna Yasmine Kirkorian, and Tanya Hinds
Mental Health Interventions for Atopic Dermatitis: Knowledge Gaps, Pilot Programs, and Future Directions, Sheena Chatrath, Jennifer LeBovidge, Carolyn Jack, Katrina Abuabara, Lynda C. Schneider, Korey Capozza, Keri Kelley, and Jonathan I. Silverberg
Phenotypic differences of atopic dermatitis stratified by age, Sheena Chatrath and Jonathan I. Silverberg
Patients' and Caregivers' Preferences for Mental Health Care and Support in Atopic Dermatitis, Albert C. Chong, Alan Schwartz, Jessica Lang, Peck Y. Ong, Ian A. Myles, Jonathan I. Silverberg, and Korey Capozza
Trends in Health Care Utilization Among United States Children With Eczema by Age, Sex, Race, and Hispanic Ethnicity: National Health Interview Survey 2006-2018, Siri Choragudi, Luis F. Andrade, Jonathan Silverberg, and Gil Yosipovitch
The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States, Raj Chovatiya, Wendy Smith Begolka, Isabelle J. Thibau, and Jonathan I. Silverberg
Prevalence of and association between atopic dermatitis and food sensitivity, food allergy and challenge-proven food allergy: A systematic review and meta-analysis, M O. Christensen, Y A. Barakji, N Loft, C M. Khatib, A Egeberg, S F. Thomsen, J I. Silverberg, C Flohr, J T. Maul, P Schmid-Grendelmeier, A S. Halling, I Vittrup, and J P. Thyssen
Systemic treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials, Alexandro W. Chu, Melanie M. Wong, Daniel G. Rayner, Gordon H. Guyatt, Juan Pablo Martinez, Renata Ceccacci, Irene X. Zhao, Eric McMullen, Archita Srivastava, Jason Wang, Aaron Wen, Fang Chi Wang, Romina Brignardello-Petersen, Ariel Izcovich, Paul Oykhman, Kathryn E. Wheeler, Julie Wang, Jonathan M. Spergel, Jasvinder A. Singh, Jonathan I. Silverberg, Peck Y. Ong, Monica O'Brien, Stephen A. Martin, Peter A. Lio, Mary Laura Lind, Jennifer LeBovidge, Elaine Kim, Joey Huynh, Matthew Greenhawt, Donna D. Gardner, Winfred T. Frazier, and Kathy Ellison
Topical treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials, Derek K. Chu, Alexandro W. Chu, Daniel G. Rayner, Gordon H. Guyatt, Juan José Yepes-Nuñez, Luis Gomez-Escobar, Lucia C. Pérez-Herrera, Juan Pablo Díaz Martinez, Romina Brignardello-Petersen, Behnam Sadeghirad, Melanie M. Wong, Renata Ceccacci, Irene X. Zhao, John Basmaji, Margaret MacDonald, Xiajing Chu, Nazmul Islam, Ya Gao, Ariel Izcovich, Rachel N. Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Korey Capozza, Lina Chen, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Jennifer LeBovidge, Peter A. Lio, Stephen A. Martin, and Monica O'Brien
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations, Derek K. Chu, Lynda Schneider, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Stephen A. Martin, Monica O'Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Kathryn E. Wheeler, and Gordon H. Guyatt
Mpox-A Rapidly Evolving Disease, Edward W. Cowen, Eric R. Tkaczyk, Scott A. Norton, and Kieron S. Leslie
Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies, Dawn M. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, and Robert Sidbury
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies, Dawn M. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, and Robert Sidbury
Efficacy and Safety of Microencapsulated Benzoyl Peroxide and Microencapsulated Tretinoin for the Treatment of Acne Vulgaris: Results from Two Phase 3 Double-Blind, Randomized, Vehicle-Controlled Studies, James Del Rosso, Jeffrey Sugarman, Lawrence Green, Theodore Lain, Ofra Levy-Hacham, Rinat Mizrahi, and Linda Stein Gold
Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study, Kilian Eyerich, Melinda J. Gooderham, Juan Francisco Silvestre, Stephen P. Shumack, Pedro Mendes-Bastos, Valeria Aoki, Michela Ortoncelli, Jonathan I. Silverberg, Henrique D. Teixeira, Shirley H. Chen, Brian M. Calimlim, Shunya Takemoto, Cristina Sancho, Björn Fritz, and Alan D. Irvine
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach, Dennyson Leandro Fonseca, Igor Salerno Filgueiras, Alexandre H. Marques, Elroy Vojdani, Gilad Halpert, Yuri Ostrinski, Gabriela Crispim Baiocchi, Desirée Rodrigues Plaça, Paula P. Freire, Shahab Zaki Pour, Guido Moll, Rusan Catar, Yael Bublil Lavi, Jonathan I. Silverberg, Jason Zimmerman, Gustavo Cabral-Miranda, Robson F. Carvalho, Taj Ali Khan, Harald Heidecke, Rodrigo J. Dalmolin, Andre Ducati Luchessi, Hans D. Ochs, Lena F. Schimke, Howard Amital, Gabriela Riemekasten, Israel Zyskind, Avi Z. Rosenberg, Aristo Vojdani, Yehuda Shoenfeld, and Otavio Cabral-Marques
JAAD Game Changers: Pityrosporum folliculitis: A retrospective review of 110 cases, Adam Friedman
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice, Melinda J. Gooderham, Andrew E. Pink, Eric L. Simpson, Jonathan I. Silverberg, Erman Güler, and Melissa Watkins
Silica-based microencapsulation used in topical dermatologic applications, Lawrence J. Green, Neal D. Bhatia, Ofer Toledano, Maya Erlich, Amy Spizuoco, Benjamin C. Goodyear, Jean Philippe York, and Jeannette Jakus
Silica-based microencapsulation used in topical dermatologic applications, Lawrence J. Green, Neal D. Bhatia, Ofer Toledano, Maya Erlich, Amy Spizuoco, Benjamin C. Goodyear, Jean Philippe York, and Jeannette Jakus
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo Bernard Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Suk-Young Yoo, Melissa Mathias, Hyunsil Han, Frank Seebach, Israel Lowy, Matthew G. Fury, and Danny Rischin
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo Bernard Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Suk-Young Yoo, Melissa Mathias, Hyunsil Han, Frank Seebach, Israel Lowy, Matthew G. Fury, and Danny Rischin
Engagement, Retention and Acceptability in a Digital Health Program for Atopic Dermatitis: Prospective Interventional Study, Sigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L. Ámundadóttir, Judit Mészáros, Jenna Huld Eysteinsdottir, Ragna H. Thorleifsdottir, Sigrídur K. Hrafnkelsdóttir, Halla Helgadottir, Saemundur Oddsson, and Jonathan I. Silverberg
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial, Emma Guttman-Yassky, Jonathan I. Silverberg, Diamant Thaçi, Kim A. Papp, Sonja Ständer, Lisa A. Beck, Brian S. Kim, Xiaofei Hu, Jianzhong Liu, Brian M. Calimlim, Namita Vigna, Jameson T. Crowley, Henrique D. Teixeira, and Jacob P. Thyssen
Increased risk of severe generalized pustular psoriasis due to tuberculosis screening delay for spesolimab initiation, Madison Hackley, Daphne Thampy, Shayan Waseh, Steven R. Feldman, Andrew Blauvelt, Jeffrey M. Weinberg, Sergio Schwartzman, Wilson Liao, Ronald Prussick, Jeffrey M. Cohen, and Sylvia Hsu
Who Is Holding the Syringe? A Survey of Truth in Advertising Among Medical Spas, Sara Hogan, Emily Wood, and Vineet Mishra
Longitudinal course of cognitive impairment in patients with atopic dermatitis, Ladonya Jackson-Cowan and Jonathan I. Silverberg
Psychiatric medication for the treatment of atopic dermatitis: A subanalysis of a systematic review, Teresa Ju, Luis F. Andrade, Maria J. Lalama, Georgia Biazus Soares, Narges Maskan Bermudez, and Jonathan I. Silverberg
Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients, Yael Lavi, Aristo Vojdani, Gilad Halpert, Kassem Sharif, Yuri Ostrinski, Israel Zyskind, Miriam T. Lattin, Jason Zimmerman, Jonathan I. Silverberg, Avi Z. Rosenberg, Yehuda Shoenfeld, and Howard Amital
Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic Review, Keon Andre Maleki-Yazdi, Anja Fog Heen, Irene X. Zhao, Gordon H. Guyatt, Erica A. Suzumura, Nima Makhdami, Lina Chen, Tonya Winders, Kathryn E. Wheeler, Julie Wang, Jonathan Spergel, Jonathan I. Silverberg, Peck Y. Ong, Monica O'Brien, Stephen A. Martin, Peter A. Lio, Mary Laura Lind, Jennifer LeBovidge, Elaine Kim, Joey Huynh, Matthew Greenhawt, Winfred T. Frazier, Kathy Ellison, Korey Capozza, Anna De Benedetto, Mark Boguniewicz, Wendy Smith Begolka, Rachel Netahe Asiniwasis, Lynda C. Schneider, and Derek K. Chu
Nano-encapsulated anandamide reduces inflammatory cytokines in vitro and lesion severity in a murine model of cutaneous lupus erythematosus, Erika T. McCormick, Andrew Draganski, Samantha Chalmers, Joseph Zahn, Sayra Garcia, Dillon Nussbaum, Adam Friedman, Chaim Putterman, and Joel Friedman
Characterizing the experience of sensitive skin: A pilot survey, Erika T. McCormick, Dillon Nussbaum, Alana Sadur, Sapana Desai, and Adam Friedman
Insights from a joint pediatric dermatology-gynecology vulvar clinic: A retrospective study, Nikita Menta, Dillon Nussbaum, Aneka Khilnani, Tazim Dowlut-McElroy, and Kaiane A. Habeshian
The (one-year) prevalence of atopic dermatitis in Brazil: A population-based telephone survey, Hélio Amante Miot, Valeria Aoki, Raquel Leão Orfali, Dirceu Solé, Márcia Carvalho Mallozi, Tatiane C. Rodrigues, and Jonathan I. Silverberg
Treatment preferences among patients with mild-to-moderate atopic dermatitis, Kelley Myers, Jonathan I. Silverberg, Shreekant Parasuraman, Anna Pierce, Lawrence F. Eichenfield, and Christine Poulos
Safety of Oral Janus Kinase Inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis, Shanthi Narla and Jonathan I. Silverberg
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials, Amy S. Paller, Jonathan I. Silverberg, Michael J. Cork, Emma Guttman-Yassky, Benjamin Lockshin, Alan D. Irvine, Moon Bum Kim, Kenji Kabashima, Zhen Chen, Yufang Lu, Ashish Bansal, Ana B. Rossi, and Arsalan Shabbir
Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis: A Post Hoc Analysis of 6 Randomized Clinical Trials, Amy S. Paller, Jonathan I. Silverberg, Michael J. Cork, Emma Guttman-Yassky, Benjamin Lockshin, Alan D. Irvine, Moon Bum Kim, Kenji Kabashima, Zhen Chen, Yufang Lu, Ashish Bansal, Ana B. Rossi, and Arsalan Shabbir
Association of vitiligo and inflammatory arthropathy in hospitalized US adults, Kevin R. Patel, Amanda M. Justiz, Ammar M. Ahmed, and Jonathan I. Silverberg
National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine, Natalia Pelet Del Toro, Rayan Yahia, Steven R. Feldman, Abby Van Voorhees, Lawrence Green, Sergio Schwartzman, Evan Siegel, Kelly M. Cordoro, Seemal R. Desai, Leon Kircik, Wilson Liao, Jason E. Hawkes, Jeffrey Weinberg, John Koo, Elizabeth Brezinski Wallace, Leah M. Howard, April Armstrong, and George Han
Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials, Hannah Penton, Sayeli Jayade, Santhani Selveindran, Marieke Heisen, Christophe Piketty, Liliana Ulianov, Zarif K. Jabbar-Lopez, Jonathan I. Silverberg, and Jorge Puelles
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 EADV Congress 2021, Andreas Pinter, Linda Stein Gold, Adam Reich, Lawrence J. Green, Morten Praestegaard, Johan Selmer, April W. Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra E. Stallknecht, Paw Trebbien, and Matthias Augustin
Facial atopic dermatitis is associated with sensitization to cow's milk, egg whites, and peanuts in children under 36 months, Meredith Tyree Polaskey, Anne Bendelow, Janak Mukherji, Brooke Buranosky, Jonathan I. Silverberg, and Anna Fishbein
Associations Between Shower and Moisturizing Practices with Atopic Dermatitis Severity: A Prospective Longitudinal Cohort Study, Uros Rakita, Trisha Kaundinya, and Jonathan I. Silverberg
Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe, Margo J. Reeder, Erin Warshaw, Srikanth Aravamuthan, Donald V. Belsito, Johannes Geier, Mark Wilkinson, Amber Reck Atwater, Ian R. White, Jonathan I. Silverberg, James S. Taylor, Joseph F. Fowler, Howard I. Maibach, Joel G. DeKoven, Timo Buhl, Nina Botto, Ana Maria Giménez-Arnau, Rosella Gallo, Christen Mowad, Claudia C. Lang, Vincent A. DeLeo, Graham Johnston, Melanie D. Pratt, Knut Brockow, Brandon L. Adler, Marie-Claude Houle, Heinrich Dickel, Marie Louise Schuttelaar, JiaDe Yu, Radoslaw Spiewak, Cory Dunnick, Francesca Larese Filon, and Skaidra Valiukeviciene
More than just methylisothiazolinone: Retrospective analysis of patients with isothiazolinone allergy in North America, 2017-2020, Margo J. Reeder, Donglin Zhang, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Jonathan I. Silverberg, Brandon L. Adler, Amber R. Atwater, James S. Taylor, Marie-Claude Houle, Donald V. Belsito, Jiade Yu, Nina Botto, Christen M. Mowad, Cory A. Dunnick, Vincent A. DeLeo, and Melanie D. Pratt
Higher Levels of Response on Clinical Atopic Dermatitis Severity Measures Are Associated with Meaningful Improvements in Patient-Reported Symptom and Quality of Life Measures: Integrated Analysis of Three Upadacitinib Phase 3 Trials, K Reich, M S. de Bruin-Weller, M Deleuran, B M. Calimlim, N Chen, X Hu, A R. Tenorio, and J I. Silverberg
Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3, Kristian Reich, Eric Simpson, Andreas Wollenberg, Robert Bissonnette, Masatoshi Abe, Tracy Cardillo, Jonathan Janes, Luna Sun, Sherry Chen, and Jonathan I. Silverberg
Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study, K Reich, J I. Silverberg, K A. Papp, M Deleuran, N Katoh, B Strober, L A. Beck, M de Bruin-Weller, T Werfel, F Zhang, P Biswas, M D. DiBonaventura, G Chan, S A. Farooqui, U Kerkmann, and C Clibborn
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study, K Reich, J I. Silverberg, K A. Papp, M Deleuran, N Katoh, B Strober, L A. Beck, M de Bruin-Weller, T Werfel, F Zhang, P Biswas, M D. DiBonaventura, G Chan, S Johnson, S A. Farooqui, U Kerkmann, and C Clibborn
Treat-to-target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis, Yael Renert-Yuval, Ester Del Duca, Bernd Arents, Robert Bissonnette, Aaron M. Drucker, Carsten Flohr, Emma Guttman-Yassky, Dirkjan Hijnen, Kenji Kabashima, Yael A. Leshem, Amy S. Paller, Jonathan I. Silverberg, Eric L. Simpson, Phyllis Spuls, Christian Vestergaard, Andreas Wollenberg, Alan D. Irvine, and Jacob P. Thyssen
Association of vitiligo with multiple cutaneous and extra-cutaneous autoimmune diseases: a nationwide cross-sectional study, Jorge A. Rios-Duarte, Maria J. Sanchez-Zapata, and Jonathan I. Silverberg
Association of Adult Atopic Dermatitis Severity With Bacterial, Viral, and Fungal Skin Infections, Jorge A. Rios-Duarte and Jonathan I. Silverberg
Assessment and Management of Sleep Disturbances in Atopic Dermatitis: A Review, Archana Samynathan, Anna B. Fishbein, Sabra M. Abbott, Genery D. Booster, Phyllis C. Zee, Stephen H. Sheldon, Gil Yosipovitch, and Jonathan I. Silverberg
Navigating the Atopic Dermatitis Toolbox: Challenging Scenarios and Shared Decision Making, Archana Samynathan and Jonathan I. Silverberg
Severe reactive infectious mucocutaneous eruption mimicking drug-induced epidermal necrolysis triggered by norovirus, Eric Sanfilippo, Kaiane Habeshian, Colleen H. Cotton, and Anna Yasmine Kirkorian
Assessment of racial and ethnic differences of atopic dermatitis severity and treatment patterns in a diverse outpatient cohort in the United States: a retrospective observational study, Eric Sanfilippo, Sneha Iyer, Nisha Patel, and Jonathan I. Silverberg
Venous Thromboembolism in Patients With Bullous Pemphigoid, Maria C. Schneeweiss, Joseph F. Merola, Richard Wyss, Jonathan I. Silverberg, and Arash Mostaghimi
Executive Summary: American Academy of Dermatology Guidelines of care for the management of atopic dermatitis in adults with topical therapies, Robert Sidbury, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, and Dawn M. Davis
Guidelines of care for the management of atopic dermatitis in adults with topical therapies, Robert Sidbury, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Aaron M. Drucker, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, and Dawn M. Davis
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines, Elaine C. Siegfried, Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo-Soccio, Dominic O. Co, Kelly M. Cordoro, Megan L. Curran, Austin M. Dalrymple, Carsten Flohr, Ken B. Gordon, Diane Hanna, Alan D. Irvine, Susan Kim, A Yasmine Kirkorian, Irene Lara-Corrales, Jill Lindstrom, Amy S. Paller, Melissa Reyes, Wendy Smith Begolka, Wynnis L. Tom, Abby S. Van Voorhees, Ruth Ann Vleugels, Lara Wine Lee, Olivia M. Davies, and Heather A. Brandling-Bennett
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids, Jonathan I. Silverberg, April Armstrong, Andrew Blauvelt, and Kristian Reich
Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE), Jonathan I. Silverberg, Robert Bissonnette, Leon Kircik, Dedee F. Murrell, Andrew Selfridge, Kris Liu, Gurpreet Ahluwalia, and Emma Guttman-Yassky